OptiNose Profit Margin

The latest profit margin for OPTN is -36.52% as of March 2025. That compares with -41.48% in the prior-year period — up 12.0% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside OptiNose's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPTN's profit margin moved from -41.48% to -36.52% — a 12.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptiNose's valuation or profitability profile.

Against Healthcare companies, OPTN currently prints -36.52% for profit margin, while the sector average sits near 15.58%. That is roughly 334.3% below the sector mean. Large gaps often invite a closer look at OptiNose's growth, margins, and balance sheet.

Profit Margin shows how effectively OptiNose converts resources into returns. At -36.52%, OPTN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -41.48% in the prior-year period — up 12.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OPTN's profit margin (-36.52%), review year-over-year change from -41.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.